Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-08-16FDA Approved: BUPROPION HYDROCHLORIDE SR — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for Bupropion Hydrochloride SR from Actavis Pharma, Inc., approving an added or amended aspect o…
-
CLINICAL_TRIALS trial_result · 2013-08-16Clinical Trial Update: Evaluating the Cost Effectiveness of ISTDP: A Quasi Experimental Study
A completed quasi-experimental study evaluates the cost effectiveness of Intensive Short-Term Dynamic Psychotherapy (ISTDP) for multiple men…
-
CLINICAL_TRIALS trial_result · 2013-08-15Clinical Trial Update: Statin for Depression in Patients Undergoing Coronary Artery Bypass Graft [Phase 3]
Phase 3 clinical trial update evaluating the use of a statin to treat depression in patients undergoing coronary artery bypass grafting.
-
CLINICAL_TRIALS trial_result · 2013-08-14Clinical Trial Update: Botulinum Toxin for the Treatment of Depression [Phase 2]
Phase 2 clinical trial update investigating botulinum toxin for treating depression has completed.
-
CLINICAL_TRIALS research · 2013-08-14Clinical Trial Update: Couplelinks.ca - An Online Intervention for Couples Affected by Breast Cancer [Phase 3]
Phase 3 clinical trial update for an online intervention (Couplelinks.ca) designed for couples affected by breast cancer to address distress…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2013-08-14Clinical Trial Update: MBCGT and Psycho-physiological Stress Regulation Group for Depression and Psycho-physiological Stress Patient [NA]
This entry reports an update on a clinical trial at National Taiwan University Hospital studying psychophysiological stress regulation for m…
-
CLINICAL_TRIALS trial_result · 2013-08-13Clinical Trial Update: Optimizing Electroconvulsive Therapy for Depression [Phase 4]
A Phase 4 clinical trial update on optimizing electroconvulsive therapy for depression, with conditions including major depressive disorder …
-
CLINICAL_TRIALS trial_result · 2013-08-13Clinical Trial Update: Assessment of Cognitive Functioning Before and After Treatment With Duloxetine [NA]
This document reports a completed clinical trial evaluating cognitive functioning before and after treatment with duloxetine in adults with …
-
CLINICAL_TRIALS research · 2013-08-13Clinical Trial Update: Functional and Neurochemical Correlates of Treatment Response in Major Depressive Disorder
This terminated clinical trial explored functional and neurochemical correlates of treatment response in major depressive disorder with trea…
-
CLINICAL_TRIALS trial_result · 2013-08-12Clinical Trial Update: A Quality of Life Study in Patients With Migraines
A Northwell Health quality-of-life study in patients with migraine and depression has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-08-09Clinical Trial Update: Childhood Adversity, Genetic Polymorphisms and Stress in First Onset Major Depression [NA]
This clinical trial update reports the completion of a study exploring how childhood adversity and genetic polymorphisms interact with stres…
-
CLINICAL_TRIALS trial_result · 2013-08-09Clinical Trial Update: Study of Probiotic GanedenBC30 for Irritable Bowel Syndrome and Major Depressive Disorder [Phase 4]
Phase 4 trial of the probiotic GanedenBC30 for major depressive disorder and irritable bowel syndrome was terminated, with results posted in…
-
CLINICAL_TRIALS trial_result · 2013-08-09Clinical Trial Update: Effect of Brain Lesion Severity on Treatment Response in Late-Life Depression [NA]
Completed clinical trial from Duke University examining whether brain lesion severity influences treatment response in late-life depression.…
-
CLINICAL_TRIALS trial_result · 2013-08-08Clinical Trial Update: A Pilot Study of Citicoline add-on Therapy in Patients With Bipolar Disorder or Major Depressive Disorder and Amphetamine Abuse or Dependence [NA]
This pilot trial evaluates citicoline as an add-on therapy for patients with bipolar disorder or major depressive disorder who also have amp…
-
CLINICAL_TRIALS trial_result · 2013-08-06Clinical Trial Update: Ketamine Anesthesia in Electroconvulsive Therapy [NA]
A Mayo Clinic trial evaluated ketamine as anesthesia for electroconvulsive therapy in patients with depression, with results posted after co…
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: Pilot Study of Duloxetine in Psychological Resilience [Phase 2]
A Phase 2 pilot study evaluating duloxetine for psychological resilience in adults with major depressive disorder has completed and posted r…
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: The Effects of Sleep Deprivation on Antidepressant Response [Phase 4]
Phase 4 clinical trial completed to evaluate how sleep deprivation affects antidepressant response in individuals with major depressive diso…
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: Sleep Deprivation Plus Paroxetine for Treating Major Depression in Elderly Individuals [Phase 4]
This clinical trial update notes the completion of a Phase 4 study evaluating the combination of sleep deprivation and paroxetine for major …
-
CLINICAL_TRIALS research · 2013-08-01Clinical Trial Update: IFH Depression Registry 2013
Registry entry update for an Institute for Family Health depression trial; the study status is currently unknown.
-
FDA approval · 2013-07-31FDA Approved: ESCITALOPRAM — Supplemental Application (Jubilant Cadista Pharmacuticals Inc.)
FDA approves Jubilant Cadista's supplemental application for escitalopram oxalate (generic escitalopram), expanding availability of a generi…
-
FDA approval · 2013-07-31FDA Approved: ESCITALOPRAM OXALATE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for escitalopram oxalate (generic antidepressant) from Quallent Pharmaceuticals Health LLC.
-
CLINICAL_TRIALS withdrawal · 2013-07-31Clinical Trial Update: Late-life Depression and Cerebral Perfusion [NA]
A clinical trial studying late-life depression and cerebral perfusion sponsored by Vanderbilt University has been withdrawn.
-
FDA approval · 2013-07-30FDA Approved: ABILIFY — Supplemental Application (Otsuka America Pharmaceutical, Inc.)
FDA approved a supplemental application for Abilify (aripiprazole) by Otsuka America Pharmaceutical, Inc. The action results in updated labe…
-
FDA approval · 2013-07-30FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approves a supplemental application for trazodone hydrochloride as a generic product under an ANDA filed by Sun Pharmaceutical Industrie…
-
FDA approval · 2013-07-26FDA Approved: DOXEPIN — Original Application (Actavis Pharma, Inc.)
The FDA approved Actavis Pharma, Inc.'s generic doxepin as an original ANDA, providing a generic option for this antidepressant.